Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Yet CRC is 90% curable with timely detection and appropriate treatment of precancerous polyps; increased screening could reduce incidence by up to 50%. As part of our focus for CRC Awareness Month, our March cyber-seminar will examine two promising initiatives which are proving effective in increasing CRC screening rates.
Rates of CRC screening are extremely low in patients at federally qualified health centers (FQHCs), which serve nearly 19 million patients annually. To address this disparity, the STOP CRC (Strategies and Opportunities to Stop Colorectal Cancer in Priority Populations) trial tests a culturally tailored, health care system–based program to improve CRC screening rates in the Oregon Community Health Information Network, a community-based collaborative network of more than 200 FQHCs. The study’s Principal Investigator, Gloria Coronado will discuss how the study’s results can provide information on how to use electronic health record resources to optimize guideline-based screening in FQHC clinics whose patient populations have disproportionately low CRC screening rates.